<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Crown N</submitter><funding>Canadian Foundation for Pharmacy</funding><pagination>E55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7356265</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(2)</volume><pubmed_abstract>A continuing professional development (CPD) program for pharmacists practicing in community and team-based primary care settings was developed and evaluated using Moore's framework for the assessment of continuing medical education. The program had three components: online lectures, a two-day training workshop, and patient case studies. Knowledge (pre-post multiple choice test); attitudes, readiness, and comfort with applying pharmacogenomics in their practices (pre-post surveys); and experiences of implementing pharmacogenomics in practice (semi-structured interviews) were assessed. Twenty-one of 26 enrolled pharmacists successfully completed the program, and were satisfied with their experience. Almost all achieved a score of 80% or higher on the post-training multiple choice test, with significantly improved scores compared to the pre-training test. Pre- and post-training surveys demonstrated that participants felt that their knowledge and competence increased upon completion of the training. In the follow-up, 15 pharmacists incorporated pharmacogenomics testing into care for 117 patients. Ten pharmacists participated in semi-structured interviews, reporting strong performance in the program, but some difficulty implementing new knowledge in their practices. This multi-component CPD program successfully increased pharmacists' knowledge, readiness, and comfort in applying pharmacogenomics to patient care in the short-term, yet some pharmacists struggled to integrate this new service into their practices.</pubmed_abstract><journal>Pharmacy (Basel, Switzerland)</journal><pubmed_title>A Continuing Professional Development Program for Pharmacists Implementing Pharmacogenomics into Practice.</pubmed_title><pmcid>PMC7356265</pmcid><funding_grant_id>Innovation Fund Grant</funding_grant_id><pubmed_authors>Crown N</pubmed_authors><pubmed_authors>Luke MJ</pubmed_authors><pubmed_authors>Sproule BA</pubmed_authors><pubmed_authors>Piquette-Miller M</pubmed_authors><pubmed_authors>McCarthy LM</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Continuing Professional Development Program for Pharmacists Implementing Pharmacogenomics into Practice.</name><description>A continuing professional development (CPD) program for pharmacists practicing in community and team-based primary care settings was developed and evaluated using Moore's framework for the assessment of continuing medical education. The program had three components: online lectures, a two-day training workshop, and patient case studies. Knowledge (pre-post multiple choice test); attitudes, readiness, and comfort with applying pharmacogenomics in their practices (pre-post surveys); and experiences of implementing pharmacogenomics in practice (semi-structured interviews) were assessed. Twenty-one of 26 enrolled pharmacists successfully completed the program, and were satisfied with their experience. Almost all achieved a score of 80% or higher on the post-training multiple choice test, with significantly improved scores compared to the pre-training test. Pre- and post-training surveys demonstrated that participants felt that their knowledge and competence increased upon completion of the training. In the follow-up, 15 pharmacists incorporated pharmacogenomics testing into care for 117 patients. Ten pharmacists participated in semi-structured interviews, reporting strong performance in the program, but some difficulty implementing new knowledge in their practices. This multi-component CPD program successfully increased pharmacists' knowledge, readiness, and comfort in applying pharmacogenomics to patient care in the short-term, yet some pharmacists struggled to integrate this new service into their practices.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar</publication><modification>2025-04-27T03:02:11.53Z</modification><creation>2025-04-06T18:40:33.168Z</creation></dates><accession>S-EPMC7356265</accession><cross_references><pubmed>32231164</pubmed><doi>10.3390/pharmacy8020055</doi></cross_references></HashMap>